Astrocytic expression of HIV-1 Nef impairs spatial and recognition memory

Neurobiology of Disease

Volumn 49, Issue 1, 2013, Pages 128-136

  Chompre, Gladys ^a   Cruz, Emmanuel ^a   Maldonado, Lucianette ^a   Rivera Amill, Vanessa ^a   Porter, James T ^a   Noel, Richard J ^a  

^a PONCE SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Astrocyte; CCL2; CD163; Cognition; HAND

Indexed keywords

GREEN FLUORESCENT PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEF PROTEIN; CCL2 PROTEIN, RAT; MESSENGER RNA; NEF PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL INFILTRATION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; GENETIC TRANSFECTION; HIPPOCAMPAL CA3 REGION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE SYSTEM; MACROPHAGE; MALE; MEMORY DISORDER; NONHUMAN; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPATIAL MEMORY; UPREGULATION; VIRUS REPLICATION; ANIMAL; ANXIETY; BRAIN TRANSPLANTATION; CELL CULTURE; GENETICS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; METABOLISM; MOTOR ACTIVITY; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RECOGNITION; SPRAGUE DAWLEY RAT;

ANIMALS; ANXIETY; ASTROCYTES; BRAIN TISSUE TRANSPLANTATION; CELLS, CULTURED; CHEMOKINE CCL2; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; LEARNING DISORDERS; MACROPHAGES; MALE; MEMORY DISORDERS; MOTOR ACTIVITY; NEF GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; NEURONS; RATS, SPRAGUE-DAWLEY; RECOGNITION (PSYCHOLOGY); RNA, MESSENGER; SPATIAL MEMORY; TRANSFECTION;

EID: 84866560640     PISSN: 09699961     EISSN: 1095953X     Source Type: Journal    
DOI: 10.1016/j.nbd.2012.08.007     Document Type: Article

References (60)

1. Acevedo S.F., Ohtsu H., Benice T.S., Rizk-Jackson A., Raber J. Age-dependent measures of anxiety and cognition in male histidine decarboxylase knockout (Hdc-/-) mice. Brain Res. 2006, 1071:113-123.
2. Anderson E., Zink W., Xiong H., Gendelman H.E. HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J. Acquir. Immune Defic. Syndr. 2002, 31(Suppl. 2):S43-S54.
3. Benice T.S., Raber J. Object recognition analysis in mice using nose-point digital video tracking. J. Neurosci. Methods 2008, 168:422-430.
4. Benice T.S., Rizk A., Kohama S., Pfankuch T., Raber J. Sex-differences in age-related cognitive decline in C57BL/6J mice associated with increased brain microtubule-associated protein 2 and synaptophysin immunoreactivity. Neuroscience 2006, 137:413-423.
5. Chauhan A., Turchan J., Pocernich C., Bruce-Keller A., Roth S., Butterfield D.A., Major E.O., Nath A. Intracellular human immunodeficiency virus Tat expression in astrocytes promotes astrocyte survival but induces potent neurotoxicity at distant sites via axonal transport. J. Biol. Chem. 2003, 278:13512-13519.
6. Churchill M.J., Wesselingh S.L., Cowley D., Pardo C.A., McArthur J.C., Brew B.J., Gorry P.R. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann. Neurol. 2009, 66:253-258.
7. Conant K., Tornatore C., Atwood W., Meyers K., Traub R., Major E.O. In vivo and in vitro infection of the astrocyte by HIV-1. Adv. Neuroimmunol. 1994, 4:287-289.
8. Dayton A.I. Hitting HIV where it hides. Retrovirology 2008, 5:15.
9. Depboylu C., Weihe E., Eiden L.E. Lentiviral infection of Rhesus macaques causes long-term injury to cortical and hippocampal projections of prostaglandin-expressing cholinergic basal forebrain neurons. J. Neuropathol. Exp. Neurol. 2012, 71:15-27. 10.1097/NEN.0b013e31823cfac5.
10. Fiala M., Singer E.J., Commins D., Mirzapoiazova T., Verin A., Espinosa A., Ugen K., Bernas M., Witte M., Weinand M., Lossinsky A.S. HIV-1 antigens in neurons of cocaine-abusing patients. Open Virol. J. 2008, 2:24-31.
11. Fischer-Smith T., Bell C., Croul S., Lewis M., Rappaport J. Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J. Neurovirol. 2008, 14:318-326.
12. Fischer-Smith T., Tedaldi E.M., Rappaport J. CD163/CD16 coexpression by circulating monocytes/macrophages in HIV: potential biomarkers for HIV infection and AIDS progression. AIDS Res. Hum. Retroviruses 2008, 24:417-421.
13. Fujii Y., Otake K., Tashiro M., Adachi A. Soluble Nef antigen of HIV-1 is cytotoxic for human CD4+ T cells. FEBS Lett. 1996, 393:93-96.
14. Gelman B.B., Soukup V.M., Schuenke K.W., Keherly M.J., Holzer C., Richey F.J., Lahart C.J. Acquired neuronal channelopathies in HIV-associated dementia. J. Neuroimmunol. 2004, 157:111-119.
15. Gelman B., Lisinicchia J., Chen T., Johnson K., Jennings K., Freeman D., Soukup V. Prefrontal dopaminergic and enkephalinergic synaptic accommodation in HIV-associated neurocognitive disorders and encephalitis. J. NeuroImmune Pharmacol. 2012, 1-15.
16. Guillemin G.J., Kerr S.J., Smythe G.A., Smith D.G., Kapoor V., Armati P.J., Croitoru J., Brew B.J. Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J. Neurochem. 2001, 78:842-853.
17. Haase A.T. Pathogenesis of lentivirus infections. Nature 1986, 322:130-136.
18. Haughey N.J., Mattson M.P. Calcium dysregulation and neuronal apoptosis by the HIV-1 proteins Tat and gp120. J. Acquir. Immune Defic. Syndr. 2002, 31(Suppl. 2):S55-S61.
19. Heaton R., Franklin D., Ellis R., McCutchan J., Letendre S., LeBlanc S., Corkran S., Duarte N., Clifford D., Woods S., Collier A., Marra C., Morgello S., Mindt M., Taylor M., Marcotte T., Atkinson J., Wolfson T., Gelman B., McArthur J., Simpson D., Abramson I., Gamst A., Fennema-Notestine C., Jernigan T., Wong J., Grant I., Charter f.t, Groups H. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J. Neurovirol. 2011, 17:3-16.
20. Henderson L.J., Narasipura S.D., Adarichev V., Kashanchi F., Al-Harthi L. Identification of novel TCF-4 binding sites on the HIV LTR which associate with TCF-4, β-catenin and SMAR1 to repress HIV transcription. J. Virol. 2012.
21. Huang M.B., Jin L.L., James C.O., Khan M., Powell M.D., Bond V.C. Characterization of Nef-CXCR4 interactions important for apoptosis induction. J. Virol. 2004, 78:11084-11096.
22. Huang Y., Zhao L., Jia B., Wu L., Li Y., Curthoys N., Zheng J.C. Glutaminase dysregulation in HIV-1-infected human microglia mediates neurotoxicity: relevant to HIV-1-associated neurocognitive disorders. J. Neurosci. 2011, 31:15195-15204.
23. Kelder W., McArthur J.C., Nance-Sproson T., McClernon D., Griffin D.E. Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann. Neurol. 1998, 44:831-835.
24. Koedel U., Kohleisen B., Sporer B., Lahrtz F., Ovod V., Fontana A., Erfle V., Pfister H.W. HIV type 1 Nef protein is a viral factor for leukocyte recruitment into the central nervous system. J. Immunol. 1999, 163:1237-1245.
25. Koutsilieri E., Czub S., Scheller C., Sopper S., Tatschner T., Stahl-Hennig C., Meulen V.t, Riederer P. Brain choline acetyltransferase reduction in SIV infection. An index of early dementia?. Neuroreport 2000, 11:2391-2393.
26. Kumar A.M., Fernandez J., Singer E.J., Commins D., Waldrop-Valverde D., Ownby R.L., Kumar M. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J. Neurovirol. 2009, 15:257-274.
27. Kumar A., Ownby R., Waldrop-Valverde D., Fernandez B., Kumar M. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance. J. Neurovirol. 2011, 17:26-40.
28. Lehmann M.H., Masanetz S., Kramer S., Erfle V. HIV-1 Nef upregulates CCL2/MCP-1 expression in astrocytes in a myristoylation- and calmodulin-dependent manner. J. Cell Sci. 2006, 119:4520-4530.
29. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 1985, 82:1257-1261.
30. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., Jacobson L.P., et al. Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS cohort study. Neurology 1993, 43:2245-2252.
31. McArthur J.C., Sacktor N., Selnes O. Human immunodeficiency virus-associated dementia. Semin. Neurol. 1999, 19:129-150.
32. McArthur J.C., Haughey N., Gartner S., Conant K., Pardo C., Nath A., Sacktor N. Human immunodeficiency virus-associated dementia: an evolving disease. J. Neurovirol. 2003, 9:205-221.
33. Messam C.A., Major E.O. Stages of restricted HIV-1 infection in astrocyte cultures derived from human fetal brain tissue. J. Neurovirol. 2000, 6(Suppl. 1):S90-S94.
34. Meulendyke K., Pletnikov M., Engle E., Tarwater P., Graham D., Zink M. Early minocycline treatment prevents a decrease in striatal dopamine in an SIV model of HIV-associated neurological disease. J. Neuroimmune Pharmacol. 2012, 7:454-464.
35. Midde N.M., Gomez A.M., Zhu J. HIV-1 Tat protein decreases dopamine transporter cell surface expression and vesicular monoamine transporter-2 function in rat striatal synaptosomes. J. Neuroimmune Pharmacol. 2012.
36. Moran L.M., Aksenov M.Y., Booze R.M., Webb K.M., Mactutus C.F. Adolescent HIV-1 transgenic rats: evidence for dopaminergic alterations in behavior and neurochemistry revealed by methamphetamine challenge. Curr. HIV Res. 2012.
37. Mordelet E., Kissa K., Cressant A., Gray F., Ozden S., Vidal C., Charneau P., Granon S. Histopathological and cognitive defects induced by Nef in the brain. FASEB J. 2004, 18:1851-1861.
38. Overholser E.D., Coleman G.D., Bennett J.L., Casaday R.J., Zink M.C., Barber S.A., Clements J.E. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J. Virol. 2003, 77:6855-6866.
39. Peluso R., Haase A., Stowring L., Edwards M., Ventura P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985, 147:231-236.
40. Popovic M., Tenner-Racz K., Pelser C., Stellbrink H.J., van Lunzen J., Lewis G., Kalyanaraman V.S., Gallo R.C., Racz P. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:14807-14812.
41. Price R.W., Brew B., Sidtis J., Rosenblum M., Scheck A.C., Cleary P. The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex. Science 1988, 239:586-592.
42. Ranki A., Nyberg M., Ovod V., Haltia M., Elovaara I., Raininko R., Haapasalo H., Krohn K. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995, 9:1001-1008.
43. Robertson K.R., Smurzynski M., Parsons T.D., Wu K., Bosch R.J., Wu J., McArthur J.C., Collier A.C., Evans S.R., Ellis R.J. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007, 21:1915-1921.
44. Sacktor N., McDermott M.P., Marder K., Schifitto G., Selnes O.A., McArthur J.C., Stern Y., Albert S., Palumbo D., Kieburtz K., De Marcaida J.A., Cohen B., Epstein L. HIV-associated cognitive impairment before and after the advent of combination therapy. J. Neurovirol. 2002, 8:136-142.
45. Saito Y., Sharer L.R., Epstein L.G., Michaels J., Mintz M., Louder M., Golding K., Cvetkovich T.A., Blumberg B.M. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994, 44:474-481.
46. Sardar A.M., Czudek C., Reynolds G.P. Dopamine deficits in the brain: the neurochemical basis of parkinsonian symptoms in AIDS. Neuroreport 1996, 7:910-912.
47. Scheller C., Sopper S., Jenuwein M., Neuen-Jacob E., Tatschner T., Grunblatt E., ter M., Riederer P., Koutsilieri E. Early impairment in dopaminergic neurotransmission in brains of SIV-infected rhesus monkeys due to microglia activation. J. Neurochem. 2005, 95:377-387.
48. Silva W., Maldonado H., Chompre G., Mayol N. Caveolae a new subcellular transport organelle. Bol. Asoc. Med. P. R. 1998, 90:30-33.
49. Sporer B., Koedel U., Paul R., Kohleisen B., Erfle V., Fontana A., Pfister H.W. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J. Neuroimmunol. 2000, 102:125-130.
50. Theodore S., Cass W.A., Maragos W.F. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience 2006, 137:925-935.
51. Theodore S., Cass W.A., Dwoskin L.P., Maragos W.F. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse 2012, 66:755-757.
52. Thompson K.A., McArthur J.C., Wesselingh S.L. Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia. Ann. Neurol. 2001, 49:745-752.
53. Tian C., Sun L., Jia B., Ma K., Curthoys N., Ding J., Zheng J. Mitochondrial glutaminase release contributes to glutamate-mediated neurotoxicity during human immunodeficiency virus-1 infection. J. Neuroimmune Pharmacol. 2012, 1-10.
54. Tornatore C., Nath A., Amemiya K., Major E.O. Persistent human immunodeficiency virus type 1 infection in human fetal glial cells reactivated by T-cell factor(s) or by the cytokines tumor necrosis factor alpha and interleukin-1 beta. J. Virol. 1991, 65:6094-6100.
55. Tornatore C., Meyers K., Atwood W., Conant K., Major E. Temporal patterns of human immunodeficiency virus type 1 transcripts in human fetal astrocytes. J. Virol. 1994, 68:93-102.
56. Torres-Munoz J., Stockton P., Tacoronte N., Roberts B., Maronpot R.R., Petito C.K. Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 2001, 60:885-892.
57. Trillo-Pazos G., McFarlane-Abdulla E., Campbell I.C., Pilkington G.J., Everall I.P. Recombinant nef HIV-IIIB protein is toxic to human neurons in culture. Brain Res. 2000, 864:315-326.
58. Van Marle G., Henry S., Todoruk T., Sullivan A., Silva C., Rourke S.B., Holden J., McArthur J.C., Gill M.J., Power C. Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 2004, 329:302-318.
59. Wang Z., Pekarskaya O., Bencheikh M., Chao W., Gelbard H.A., Ghorpade A., Rothstein J.D., Volsky D.J. Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120. Virology 2003, 312:60-73.
60. Wiley C.A., Schrier R.D., Nelson J.A., Lampert P.W., Oldstone M.B. Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc. Natl. Acad. Sci. U. S. A. 1986, 83:7089-7093.